New methods of evaluate endothelial function: Evaluation of endothelial function by hemoglobin-nitric oxide complex using electron paramagnetic resonance spectroscopy

Journal of Pharmacological Sciences

Volumn 93, Issue 4, 2003, Pages 417-422

  Tsuchiya, Koichiro ^a   Kirima, Kazuyoshi ^a   Yoshizumi, Masanori ^a   Tamaki, Toshiaki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Electron paramagnetic resonance (EPR); Hemoglobin NO adduct; Nitric oxide (NO); Temocapril

Indexed keywords

CERULOPLASMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DITHIOCARBAMIC ACID DERIVATIVE; HEMOGLOBIN; IRON COMPLEX; N METHYLGLUCAMINE N CARBODITHIOIC ACID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; TEMOCAPRIL;

ASSAY; ENDOTHELIUM; ENDOTHELIUM INJURY; HUMAN; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; MAGNETIC FIELD; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; REVIEW;

ANIMALS; ELECTRON SPIN RESONANCE SPECTROSCOPY; ENDOTHELIUM, VASCULAR; FERROUS COMPOUNDS; HEMOGLOBIN A, GLYCOSYLATED; NITRIC OXIDE; RATS; SPIN TRAPPING; THIOCARBAMATES;

EID: 1042292679     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.93.417     Document Type: Review

References (73)

1. Rees DD, Palmer RM, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA. 1989;86:3375-3378.
2. Fang FC. Perspectives series: Host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest. 1997;99:2818-2825.
3. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992;6:3051-3064.
4. Snyder SH, Jaffrey SR, Zakhary R. Nitric oxide and carbon monoxide: Parallel roles as neural messengers. Brain Res Brain Res Rev. 1998;26:167-175.
5. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
6. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 1987;84:9265-9269.
7. Greenberg SS, Wilcox DE, Rubanyi GM. Endothelium-derived relaxing factor released from canine femoral artery by acetylcholine cannot be identified as free nitric oxide by electron paramagnetic resonance spectroscopy. Circ Res. 1990;67:1446-1452.
8. Archer S. Measurement of nitric oxide in biological models. FASEB J. 1993;7:349-360.
9. Lewko B, Wendt U, Szczepanska-Konkel M, Stepinski J, Drewnowska K, Angielski S. Inhibition of endogenous nitric oxide synthesis activates particulate guanylyl cyclase in the rat renal glomeruli. Kidney Int. 1997;52:654-659.
10. Valdivielso JM, Crespo C, Alonso JR, et al. Renal ischemia in the rat stimulates glomerular nitric oxide synthesis. Am J Physiol Regul Integr Comp Physiol. 2001;280:R771-R779.
11. Kuchan MJ, Frangos JA. Role of calcium and calmodulin in flow-induced nitric oxide production in endothelial cells. Am J Physiol. 1994;266:C628-C636.
12. Umino T, Kusano E, Muto S, et al. AVP inhibits LPS- and IL-1beta-stimulated NO and cGMP via V1 receptor in cultured rat mesangial cells. Am J Physiol. 1999;276:F433-F441.
13. Arroyo CM, Kohno M. Difficulties encountered in the detection of nitric oxide (NO) by spin trapping techniques. A cautionary note. Free Radic Res Commun. 1991;14:145-155.
14. Mordvintcev P, Mulsch A, Busse R, Vanin A. On-line detection of nitric oxide formation in liquid aqueous phase by electron paramagnetic resonance spectroscopy. Anal Biochem. 1991; 199: 142-146.
15. .NO through a radical reaction. Biochemistry. 1993;32:827-832.
16. Komarov A, Mattson D, Jones MM, Singh PK, Lai CS. In vivo spin trapping of nitric oxide in mice. Biochem Biophys Res Commun. 1993;195:1191-1198.
17. Woldman Y, Khramtsov VV, Grigor'ev IA, Kiriljuk IA, Utepbergenov DI. Spin trapping of nitric oxide by nitronylnitroxides: Measurement of the activity of NO synthase from rat cerebellum. Biochem Biophys Res Commun. 1994;202:195-203.
18. Eich RF, Li T, Lemon DD, et al. Mechanism of NO-induced oxidation of myoglobin and hemoglobin. Biochemistry. 1996;35:6976-6983.
19. - under argon and in air. Chem Res Toxicol. 1996;9:1382-1390.
20. .-mediated oxidation of oxymyoglobin and oxyhemoglobin. Biochemistry. 2001;40:3385-3395.
21. Witting PK, Douglas JK, Mauk AG. Reaction of human myoglobin and nitric oxide. Heme iron or protein sulfhydryl (s) nitrosation dependence on the absence or presence of oxygen. J Biol Chem. 2001;276:3991-3998.
22. Pawloski JR, Hess DT, Stamler JS. Export by red blood cells of nitric oxide bioactivity. Nature. 2001;409:622-626.
23. Yonetani T, Tsuneshige A, Zhou Y, Chen X. Electron paramagnetic resonance and oxygen binding studies of alpha-nitrosyl hemoglobin. A novel oxygen carrier having NO-assisted allosteric functions. J Biol Chem. 1998;273:20323-20333.
24. Wang QZ, Jacobs J, DeLeo J, et al. Nitric oxide hemoglobin in mice and rats in endotoxic shock. Life Sci. 1991;49:L55-L60.
25. Westenberger U, Thanner S, Ruf HH, Gersonde K, Sutter G, Trentz O. Formation of free radicals and nitric oxide derivative of hemoglobin in rats during shock syndrome. Free Radic Res Commun. 1990;11:167-178.
26. Cantilena LR Jr, Smith RP, Frasur S, Kruszyna H, Kruszyna R, Wilcox DE. Nitric oxide hemoglobin in patients receiving nitroglycerin as detected by electron paramagnetic resonance spectroscopy. J Lab Clin Med. 1992;120:902-907.
27. Kohno M, Masumizu T, Mori A. ESR demonstration of nitric oxide production from nitroglycerin and sodium nitrite in the blood of rats. Free Radic Biol Med. 1995;18:451-457.
28. Roccatello D, Mengozzi G, Alfieri V, et al. Early increase in blood nitric oxide, detected by electron paramagnetic resonance as nitrosylhaemoglobin, in haemodialysis. Nephrol Dial Transplant. 1997;12:292-297.
29. Takahashi Y, Kobayashi H, Tanaka N, Sato T, Takizawa N, Tomita T. Nitrosyl hemoglobin in blood of normoxic and hypoxic sheep during nitric oxide inhalation. Am J Physiol. 1998;274:H349-H357.
30. Weinberg JB, Gilkeson GS, Mason RP, Chamulitrat W. Nitrosylation of blood hemoglobin and renal nonheme proteins in autoimmune MRL-lpr/lpr mice. Free Radic Biol Med. 1998;24:191-196.
31. McMahon TJ, Moon RE, Luschinger BP, et al. Nitric oxide in the human respiratory cycle. Nat Med. 2002;8:711-717.
32. Jaszewski AR, Fann YC, Chen Y-R, Sato K, Corbett J, Mason RP. EPR spectroscopy studies on the structural transition of nitrosyl hemoglobin in the arterial-venous cycle of DEANO-treated rats as its relates to the proposed nitrosyl hemoglobin/nitrosothiol hemoglobin exchange. Free Radical Biol Med. 2003;35:444-451.
33. Nakazawa H, Ichimori K, Shinozaki Y, Okino H, Hori S. Is superoxide demonstration by electron-spin resonance spectroscopy really superoxide? Am J Physiol. 1988;255:H213-H215.
34. Baker JE, Felix CC, Olinger GN, Kalyanaraman B. Myocardial ischemia and reperfusion: Direct evidence for free radical generation by electron spin resonance spectroscopy. Proc Natl Acad Sci USA. 1988;85:2786-2789.
35. Hall DM, Buettner GR. In vivo spin trapping of nitric oxide by heme: Electron paramagnetic resonance detection ex vivo. Methods Enzymol. 1996;268:188-192.
36. Bazzani C, Bini A, Cainazzo MM, et al. High blood levels of nitric oxide in rats subjected to prolonged respiratory arrest and their modulation during adrenocorticotropin-induced resuscitation. Naunyn Schmiedebergs Arch Pharmacol. 1999;359:53-59.
37. Glover RE, Germolec DR, Patterson R, Walker NJ, Lucier GW, Mason RP. Endotoxin (lipopolysaccharide)-induced nitric oxide production in 2,3,7,8-tetrachloridibenzo-p-dioxin-treated Fisher rats: Detection of nitrosyl hemoproteins by EPR spectroscopy. Chem Res Toxicol. 2000;13:1051-1055.
38. Vedernikov YP, Mordvintcev PI, Malenkova IV, Vanin AF. Effect of diethyldithiocarbamate on the activity of nitric oxide-releasing vasodilators. Eur J Pharmacol. 1992;212:125-128.
39. Mordvintcev P, Mulsch A, Busse R, Vanin A. On-line detection of nitric oxide formation in liquid aqueous phase by electron paramagnetic resonance spectroscopy. Anal Biochem. 1991;199:142-146.
40. Obolenskaya M, Vanin AF, Mordvintcev PI, Mulsch A, Decker K. EPR evidence of nitric oxide production by the regenerating rat liver. Biochem Biophys Res Commun. 1994;202:571-576.
41. Tsuchiya K, Takasugi M, Minakuchi K, Fukuzawa K. Sensitive quantitation of nitric oxide by EPR spectroscopy. Free Radic Biol Med. 1996;21:733-737.
42. Shinobu LA, Jones SG, Jones MM. Sodium N-methyl-D-glucamine dithiocarbamate and cadmium intoxication. Acta Pharmacol Toxicol (Copenh). 1984;54:189-194.
43. Hiramoto K, Tomiyama S, Kikugawa K. Appearance of electron spin resonance signals in the interaction of dithiocarbamate-Fe(II) with nitrogen dioxide and nitrite. Free Radic Res. 1997;27:505-509.
44. Tsuchiya K, Yoshizumi M, Houchi H, Mason RP. Nitric oxide-forming reaction between the iron-N-methyl-D-glucamine dithiocarbamate complex and nitrite. J Biol Chem. 2000;275:1551-1556.
45. Tsuchiya K, Kirima K, Yoshizumi M, Houchi H, Tamaki T, Mason RP. The role of thiol and nitrosothiol compounds in the nitric oxide-forming reactions of the iron-N-methyl-D-glucamine dithiocarbamate complex. Biochem J. 2002;367:771-779.
46. Tsuchiya K, Jiang JJ, Yoshizumi M, et al. Nitric oxide-forming reaction of the water-soluble nitric oxide spin-trapping agent, MGD. Free Radic Biol Med. 1999;27:347-355.
47. 2+ with diethyldithiocarbamate or N-methyl-D-glucamine dithiocarbamate as traps of nitric oxide in animal tissues: Comparative investigations. Biochim Biophys Acta. 1997;1336:225-234.
48. Pawloski JR, Hess DT, Stamler JS. Export by red blood cells of nitric oxide bioactivity. Nature. 2001;409:622-626.
49. G-nitroarginine. Biochemistry. 1993;32:8512-8517.
50. G-methylarginine. Biochem Biophys Res Commun. 1990;170:96-103.
51. Rees DD, Palmer RM, Schulz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 1990;101:746-752.
52. Cadnapaphornchai MA, Ohara M, Morris KG Jr., et al. Chronic NOS inhibition reverses systemic vasodilation and glomerular hyperfiltration in pregnancy. Am J Physiol Renal Physiol. 2001;280:F592-F598.
53. Martin PY, Ohara M, Gines P, et al. Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites. J Clin Invest. 1998;101:235-242.
54. Kubes P, Suzuki M, Granger DN. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA. 1991;88:4651-4655.
55. Randomski MW, Palmer RM, Moncada S. Characterization of the L-arginine: Nitric oxide pathway in human platelets. Br J Pharmacol. 1990;101:325-328.
56. Bauersachs J, Bouloumie A, Fraccarollo D, Hu K, Busse R, Ertl G. Hydralazine prevents endothelial dysfunction, but not the increase in superoxide production in nitric oxide-deficient hypertension. Eur J Pharmacol. 1998;362:77-81.
57. Katoh M, Egashira K, Usui M, et al. Cardiac angiotensin II receptors are upregulated by long-term inhibition of nitric oxide synthesis in rats. Circ Res. 1998;83:743-751.
58. Takase H, Moreau P, Kung CF, Nava E, Luscher TF. Anti-hypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency. Effect of verapamil and trandolapril. Hypertension. 1996;27:25-31.
59. Glover RE, Ivy ED, Orringer EP, Maeda H, Mason RP. Detection of nitrosyl hemoglobin in venous blood in the treatment of sickle cell anemia with hydroxyurea. Mol Pharmacol. 1999;55:1006-1010.
60. Kozlov AV, Bini A, Iannone A, Zini I, Tomasi A. Electron paramagnetic resonance characterization of rat neuronal nitric oxide production ex vivo. Methods Enzymol. 1996;268:229-236.
61. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666.
62. Sakuma I, Stuehr DJ, Gross SS, Nathan C, Levi R. Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc Natl Acad Sci USA. 1988;85:8664-8667.
63. Kirima K, Tsuchiya K, Sei H, et al. Evaluation of systemic blood NO dynamics by EPR spectroscopy: HbNO as an endogenous index of NO. Am J Physiol Heart Circ Physiol. 2003;285:H589-H596.
64. Amann K, Gassmann P, Buzello M, et al. Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic rats. Kidney Int. 2000;58:153-161.
65. Higashi Y, Oshima T, Sasaki S, et al. Angiotensin-converting enzyme inhibition, but not calcium antagonism, improves a response of the renal vasculature to L-arginine in patients with essential hypertension. Hypertension. 1998;32:16-24.
66. Linz W, Jessen T, Becker RH, Scholkens BA, Wiemer G. Long-term ACE inhibition doubles lifespan of hypertensive rats. Circulation. 1997;96:3164-3172.
67. Mancini GB, Henry GC, Macaya C, et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation. 1996;94:258-265.
68. Takata M, Ueno H, Hirai T, Oh-Hashi S, Yasumoto K, Inoue H. Time course of the effects of temocapril on cardiovascular structure and function in patients with essential hypertension. J Cardiovasc Pharmacol. 1999;34:561-566.
69. Varin R, Mulder P, Tamion F, et al. Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure: Role of nitric oxide, prostanoids, oxidant stress, and bradykinin. Circulation. 2000;102:351-356.
70. Ishizuka H, Konno K, Naganuma H, et al. Temocaprilat, a novel angiotensin-converting enzyme inhibitor, is excreted in bile via an ATP-dependent active transporter (cMOAT) that is deficient in Eisai hyperbilirubinemic mutant rats (EHBR). J Pharmacol Exp Ther. 1997;280:1304-1311.
71. Oda T, Iijima Y, Sada T, Nishino H, Oizumi K, Koike H. Effects of chronic treatment with a novel angiotensin converting enzyme inhibitor, CS622, and a vasodilator, hydralazine, on atrial natriuretic factor (ANF) in spontaneously hypertensive rats (SHR). Biochem Biophys Res Commun. 1988;152:456-462.
72. Tsuchiya K, Kirima K, Yoshizumi M, Houchi H, Tamaki T, Mason RP. The role of thiol and nitrosothiol compounds in the nitric oxide-forming reactions of the iron-N-methyl-D-glucamine dithiocarbamate complex. Biochem J. 2002;367:771-779.
73. Vanin AF, Huisman A, Van Faassen EE. Iron dithiocarbamate as spin trap for nitric oxide detection: Pitfalls and successes. Methods Enzymol. 2002;359:27-42.